Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making

Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved...

Full description

Bibliographic Details
Main Author: Tatiana Martins Tilli
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/12/1348
_version_ 1797503133221388288
author Tatiana Martins Tilli
author_facet Tatiana Martins Tilli
author_sort Tatiana Martins Tilli
collection DOAJ
description Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years?
first_indexed 2024-03-10T03:46:10Z
format Article
id doaj.art-aea78804e55b46bfbed6e6ea1f30df96
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-10T03:46:10Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-aea78804e55b46bfbed6e6ea1f30df962023-11-23T09:08:18ZengMDPI AGJournal of Personalized Medicine2075-44262021-12-011112134810.3390/jpm11121348Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision MakingTatiana Martins Tilli0Translational Oncology Platform, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, BrazilBreast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years?https://www.mdpi.com/2075-4426/11/12/1348breast cancerprecision medicinetechnologydiagnosistreatment
spellingShingle Tatiana Martins Tilli
Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
Journal of Personalized Medicine
breast cancer
precision medicine
technology
diagnosis
treatment
title Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_full Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_fullStr Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_full_unstemmed Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_short Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_sort precision medicine technological impact into breast cancer diagnosis treatment and decision making
topic breast cancer
precision medicine
technology
diagnosis
treatment
url https://www.mdpi.com/2075-4426/11/12/1348
work_keys_str_mv AT tatianamartinstilli precisionmedicinetechnologicalimpactintobreastcancerdiagnosistreatmentanddecisionmaking